↓ Skip to main content

Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer

Overview of attention for article published in European Journal of Nuclear Medicine and Molecular Imaging, August 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy
1 policy source
patent
32 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
151 Dimensions

Readers on

mendeley
54 Mendeley
Title
Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer
Published in
European Journal of Nuclear Medicine and Molecular Imaging, August 2006
DOI 10.1007/s00259-006-0190-7
Pubmed ID
Authors

Bernhard Scher, Michael Seitz, Wolfram Albinger, Reinhold Tiling, Michael Scherr, Hans-Christoph Becker, Michael Souvatzogluou, Franz-Josef Gildehaus, Hans-Jürgen Wester, Stefan Dresel

Abstract

The value and limitations of (11)C-choline PET and PET/CT for the detection of prostate cancer remain controversial. The aim of this study was to investigate the diagnostic efficacy of (11)C-choline PET and PET/CT in a large group of patients with suspected prostate cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Canada 1 2%
Unknown 52 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 22%
Professor > Associate Professor 6 11%
Researcher 5 9%
Student > Ph. D. Student 5 9%
Student > Bachelor 2 4%
Other 10 19%
Unknown 14 26%
Readers by discipline Count As %
Medicine and Dentistry 19 35%
Agricultural and Biological Sciences 6 11%
Physics and Astronomy 3 6%
Computer Science 2 4%
Engineering 2 4%
Other 5 9%
Unknown 17 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#2,608,009
of 23,806,312 outputs
Outputs from European Journal of Nuclear Medicine and Molecular Imaging
#201
of 3,083 outputs
Outputs of similar age
#5,204
of 67,950 outputs
Outputs of similar age from European Journal of Nuclear Medicine and Molecular Imaging
#1
of 23 outputs
Altmetric has tracked 23,806,312 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,083 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 67,950 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.